HIV drugs | News Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

42,861 results for “HIV drugs”

HIV Drugs Show Promising Potential to Reduce Alzheimer's Risk by Up to 13% Annually

HIV Drugs Show Promise as First Prophylactic Treatment for HTLV-1 Virus in Landmark Australian Study

KEMRI Advocates for Approval of Cabotegravir and Lenacapavir for HIV Prevention in Kenya

Gilead Sciences Terminates HIV Drug Trial After FDA Maintains Safety Hold

Gilead's HIV Drug Sales Fuel Q3 Beat; Raises Full-Year Guidance

Gilead Sciences Resolves Major Patent Disputes with $1.25B Settlement to ViiV and Agreement with US Government

India Emerges as Key Hub for HIV/AIDS Drug Clinical Trials

GSK's Experimental Hepatitis B Drug Bepirovirsen Achieves Functional Cure in Pivotal Studies

Gilead's HIV Prevention Drug Yeztugo Exceeds Launch Expectations, Projected to Reach $5 Billion by 2031

FDA Places Clinical Hold on Gilead's Weekly HIV Combination Therapy Following Safety Signal

Page 1 of 1040